Is Vaping CBD Better Than THC?

CBD THC Chemical Structure

It depends on what context one is talking about. CBD isolate vaping is safer but associated with fewer health benefits. In comparison, THC vape pens have greater health benefits, though they are more likely to cause side effects. It is also vital to understand that the primary cannabinoid in THC vapes is still CBD, so the difference between the two is not essentially massive. THC vapes are essentially CBD vapes with the power of THC, minor cannabinoids, terpenes, more potent entourage effects, and more (1,2).

Both CBD and THC are major cannabinoids in weed or marijuana. However, in legally grown hemp, from which CBD products are mostly made, even THC is not a major cannabinoid. In the UK, legally grown hemp varieties do not produce much THC, making them naturally low THC. Full-spectrum cannabis extract from these plants is naturally low in THC and meets the legal requirements of the nation.

Understanding CBD and THC

CBD (Cannabidiol) is a non-psychoactive compound, meaning it doesn’t produce the “high” associated with cannabis use. It is known for its potential therapeutic benefits, including reducing anxiety, pain, inflammation, and seizures. CBD is often extracted from hemp, a variety of cannabis that contains low levels of THC.

THC is the primary psychoactive compound in cannabis, responsible for the euphoric and mind-altering effects. It is used both recreationally and medicinally, with potential benefits such as pain relief, appetite stimulation, and mood enhancement. THC is typically found in higher concentrations in marijuana plants.

But, as already said, THC vapes produced legally and sold in the UK are made using hemp extract, which is naturally low in THC. So, vapes that contain THC may have some added health benefits. However, the THC content in those vapes is just enough to experience their health effects without a high.

Benefits of Vaping CBD Vs. THC

One of the main advantages of vaping CBD is that it doesn’t produce a high. This makes it an attractive option for individuals who want to experience the potential health benefits of cannabis without the psychoactive effects. This can be particularly important for those who need to maintain mental clarity and functionality throughout the day.

CBD has been studied for its potential to help with a variety of conditions, including anxiety, chronic pain, and epilepsy. So, CBD is an extensively studied substance by science.

In many regions, including the UK, CBD is legal and widely available, provided it contains no more than 1 mg of THC per container. This makes CBD products more accessible than those containing higher levels of THC, which are often subject to stricter regulations.

CBD is generally well-tolerated, with few side effects. When side effects do occur, they are typically mild and may include drowsiness, dry mouth, or changes in appetite.

THC may cause euphoria at higher dosages. However, THC vapes do not contain it in massive amounts. They just contain some THC, which is less than 1 mg per vape pen or container. This is not known to cause a high. However, even this small amount is enough to experience its health benefits. THC can modulate endocannabinoid receptors in smaller dosages, too.

So, theoretically, if one can tolerate THC in small amounts well (most people can), THC vaping is a better option. THC vaping is also about a higher content of various minor cannabinoids and a better terpene profile. Thus, THC vaping results in a better vaping experience.

The Bottom Line

CBD and THC vaping each has its pros and cons. CBD is well known to be safe and has many health benefits. THC vapes also contain CBD and minor cannabinoids, making these vapes stronger and having greater health effects. However, THC vapes are also more likely to cause side effects, though the increase in the risk is minute.

References

  1. Ferber SG, Namdar D, Hen-Shoval D, Eger G, Koltai H, Shoval G, et al. The “Entourage Effect”: Terpenes Coupled with Cannabinoids for the Treatment of Mood Disorders and Anxiety Disorders. Curr Neuropharmacol. 2020 Feb;18(2):87–96.
  2. Walsh KB, McKinney AE, Holmes AE. Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses. Front Pharmacol. 2021 Nov 29;12:777804.